Oxbryta (voxelotor)

voxelotor · Pfizer (formerly Global Blood Therapeutics)

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Oxbryta (voxelotor), covering 2024-07-24 to 2024-07-24. Get the full timeline:

Most recent: Clinical Trial Update: Voxelotor for Improving Oxygen Saturation in Adults [Phase 2]